BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 81681)

  • 21. [Beta-thromboglobulin (author's transl)].
    Endo Y
    Rinsho Byori; 1981 Jan; 29(1):20-5. PubMed ID: 6169853
    [No Abstract]   [Full Text] [Related]  

  • 22. Template bleeding time and clinical hemorrhage in myeloproliferative disease.
    Murphy S; Davis JL; Walsh PN; Gardner FH
    Arch Intern Med; 1978 Aug; 138(8):1251-3. PubMed ID: 277084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abnormal plasma concentrations of beta-thromboglobulin in chronic myelocytic leukemia and primary thrombocythemia.
    Endo Y; Mamiya S; Sato M; Takahashi K
    Nihon Ketsueki Gakkai Zasshi; 1979 Aug; 42(4):699-701. PubMed ID: 92163
    [No Abstract]   [Full Text] [Related]  

  • 24. Classification of thrombocytosis based on platelet function tests: correlation with hemorrhagic and thrombotic complications.
    Zucker S; Mielke CH
    J Lab Clin Med; 1972 Sep; 80(3):385-94. PubMed ID: 5055386
    [No Abstract]   [Full Text] [Related]  

  • 25. Does the beta TG/PF4 ratio have any value in myeloproliferative diseases?
    Viero P; Cortelazzo S; Barbui T
    Thromb Haemost; 1984 Jul; 51(3):411. PubMed ID: 6208631
    [No Abstract]   [Full Text] [Related]  

  • 26. PF 4 versus beta TG as evidence for platelet activation in myeloproliferative disorders.
    Luzzatto G; Fabris F; Mazzucato M; Girolami A
    Scand J Haematol; 1985 Sep; 35(3):299-304. PubMed ID: 2414843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blood platelet and "extra-platelet" serotonin in some myeloproliferative disorders.
    Culebras Poza JM; Launay JM; Briere J; Dreux C
    Biomedicine; 1977 Nov; 27(8):300-3. PubMed ID: 597565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Thrombohaemorrhagic syndrome in patients with a myeloproliferative disease with thrombocythemia].
    Penka M; Kissová J; Buliková A; Zavrelová J; Ovesná J; Pavlík T
    Vnitr Lek; 2011 Mar; 57(3):306-11. PubMed ID: 21495413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelets in myeloproliferative disorders. I. A comparative evaluation with certain platelet function tests.
    Boneu B; Nouvel C; Sie P; Caranobe C; Combes D; Laurent G; Pris J; Bierme R
    Scand J Haematol; 1980 Sep; 25(3):214-20. PubMed ID: 7466310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bleeding and thrombosis in the myeloproliferative disorders.
    Schafer AI
    Blood; 1984 Jul; 64(1):1-12. PubMed ID: 6375757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The value of beta TG/PF4 ratio in patients with high platelet count.
    Fabris F; Luzzatto G; Girolami A
    Thromb Haemost; 1985 Apr; 53(2):288-9. PubMed ID: 2410998
    [No Abstract]   [Full Text] [Related]  

  • 32. [Pseudohyperkalemia in the serum in reactive thrombocytosis and thrombocythemia].
    Mödder B; Meuthen I
    Dtsch Med Wochenschr; 1986 Feb; 111(9):329-32. PubMed ID: 3948731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radioimmunoassay of platelet factor 4 and beta-thromboglobulin: development and application to studies of platelet release in relation to fibrinopeptide A generation.
    Kaplan KL; Nossel HL; Drillings M; Lesznik G
    Br J Haematol; 1978 May; 39(1):129-46. PubMed ID: 78721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet function in patients with high platelet counts.
    Ginsburg AD
    Ann Intern Med; 1975 Apr; 82(4):506-11. PubMed ID: 1054537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic myeloproliferative disorders: a quantitative assessment of platelet ultrastructure.
    Boughton BJ; Jerrome DW; Rychetnik M
    Acta Haematol; 1980; 64(6):319. PubMed ID: 6782797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Phospholipids and platelet procoagulant activity in myeloproliferative syndromes].
    Martínez E; César J; Navarro JL; Mercado A; Pardo A; García Avello A; García Frade J
    Sangre (Barc); 1985; 30(1):22-7. PubMed ID: 4039850
    [No Abstract]   [Full Text] [Related]  

  • 37. Platelet aggregation in platelet-rich plasma and whole blood in 120 patients with myeloproliferative disorders.
    Balduini CL; Bertolino G; Noris P; Piletta GC
    Am J Clin Pathol; 1991 Jan; 95(1):82-6. PubMed ID: 1987755
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term interferon therapy for thrombocytosis in myeloproliferative diseases.
    Gisslinger H; Ludwig H; Linkesch W; Chott A; Fritz E; Radaszkiewicz T
    Lancet; 1989 Mar; 1(8639):634-7. PubMed ID: 2564458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relation of platelet abnormalities to thrombosis and hemorrhage in chronic myeloproliferative disorders.
    Wehmeier A; Südhoff T; Meierkord F
    Semin Thromb Hemost; 1997; 23(4):391-402. PubMed ID: 9263357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelet and fibrinogen kinetics in the chronic myeloproliferative disorders.
    Brodsky I; Kahn SB; Ross EM; Petkov G
    Cancer; 1972 Dec; 30(6):1444-50. PubMed ID: 4509103
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.